The Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1998

Citation, commencement and interpretation

1.—(1) This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Amendment Order 1998 and shall come into force on 16th September 1998.

(2) In this Order, “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (General Sale List) Order 1984(1).

(3) In this Order, a reference to a numbered column in a Table, unless otherwise indicated, is a reference to the column bearing that number in Table A, or as the case may be, Table B, of the specified Schedule to the principal Order.

Amendment of Schedule 1 to the principal Order

2.—(1) Schedule 1 to the principal Order (which specifies the class of medicinal products, other than products the subject of a product licence of right, on general sale by virtue of article 2(a) of the principal Order) is amended in accordance with the following provisions of this article.

(2) In Table A (internal and external use)—

(a) against the entry in column 1 for “Lignocaine”(2)—

(i) there is substituted in column 2 for the entry “(2) 0.6 per cent”, the entry “(2) 2.0 per cent”, and

(ii) there are inserted in column 3, after the words “except local ophthalmic use”, the words “, for use in adults and in children aged 12 years and over”;

(b) there are deleted the entry “Phenolphthalein” in column 1 and the corresponding text “120 mg (MD)” in column 4; and

(c) there are inserted in column 1, at the appropriate point in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 of Schedule 1 to this Order, and against the entry “Potassium Chloride” inserted in column 1 by virtue of this sub-paragraph, there is inserted in columns 2 and 3 the corresponding text in columns 2 and 3 of Schedule 1 to this Order.

(3) In Table B (external use only)—

(a) there are inserted in column 1, at the appropriate point in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 of Schedule 2 to this Order; and

(b) against the entry “Benzocaine” inserted in column 1 by virtue of this paragraph, there is inserted in columns 2 and 3 the corresponding text in columns 2 and 3 of Schedule 2 to this Order.

Amendment of Schedule 2 to the principal Order

3.  In Table A of Schedule 2 to the principal Order (which specifies the class of medicinal products, the subject of a product licence of right, on general sale by virtue of article 2(b) of the principal Order) there are deleted the entry “Phenolphthalein” in column 1 and the corresponding text “120 mg (MD)” in column 4.

Signed by authority of the Secretary of State for Health

Paul Boateng

Parliamentary Under Secretary of State,

Department of Health

27th August 1998

Jon Owen Jones

Parliamentary Under Secretary of State, The Welsh Office

2nd September 1998

Sam Galbraith

Minister for Health, The Scottish Office

2nd September 1998

Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on

L.S.

D.C. Gowdy

Permanent Secretary

2nd September 1998.